Actively Recruiting
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
Led by Nanfang Hospital, Southern Medical University · Updated on 2025-04-16
800
Participants Needed
1
Research Sites
465 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
From January 1, 2023 to December 30, 2023, patients who were suspected of pulmonary embolism and underwent CTPA examination at Nanyang Hospital of Southern Medical University were divided into pulmonary embolism group and non pulmonary embolism group. 1. Collect relevant data, including gender, age, primary disease, CTPA imaging and reports, BNP, troponin, electrocardiogram, cardiac ultrasound, PT, APTT, TT, fibrinogen, D-dimer, etc., and analyze demographic data, pulmonary embolism risk grading, APTT/fibrinogen ratio, and determine their cut-off values through statistical analysis of the two groups. 2. Follow up on the APTT/fibrinogen ratio after anticoagulation treatment and bleeding in the pulmonary embolism group.
CONDITIONS
Official Title
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntarily signed informed consent
- Age 18 years or older at the time of consent
- Diagnosed with suspected pulmonary embolism and underwent enhanced pulmonary artery scanning at Southern Medical University between January 1, 2023 and December 30, 2023
You will not qualify if you...
- Gastrointestinal bleeding, severe trauma, acute coronary syndrome, severe liver disease (Child C grade), or coagulation dysfunction
- Pulmonary embolism diagnosed outside the hospital with regular anticoagulation
- On regular anticoagulant therapy such as for atrial fibrillation or valve replacement
- Deemed unsuitable for participation by the researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanfang hospital of Southern Medical University
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
X
Xintong Huang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here